Atria Wealth Solutions’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $227K | Sell |
|
|||||
|
2024
Q4 | $267K | Hold |
|
|||||
|
2024
Q3 | $570K | Sell |
|
|||||
|
2024
Q2 | $483K | Sell |
|
|||||
|
2024
Q1 | $513K | Sell |
|
|||||
|
2023
Q4 | $415K | Sell |
|
|||||
|
2023
Q3 | $499K | Sell |
|
|||||
|
2023
Q2 | $376K | Sell |
|
|||||
|
2023
Q1 | $553K | Sell |
|
|||||
|
2022
Q4 | $306K | Sell |
|
|||||
|
2022
Q3 | $454K | Sell |
|
|||||
|
2022
Q2 | $369K | Sell |
|
|||||
|
2022
Q1 | $460K | Buy |
|